Gross Profit (TTM) Chart

View Gross Profit (TTM) for BXRXQ.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Gross Profit (TTM) Chart
Start Trial

Historical Gross Profit (TTM) Data

View and export this data back to 2018. Start Trial.
Date Value
September 30, 2023 -4.833M
June 30, 2023 -4.64M
March 31, 2023 -4.671M
December 31, 2022 -5.326M
September 30, 2022 -1.604M
June 30, 2022 -2.475M
March 31, 2022 -3.486M
December 31, 2021 -4.181M
September 30, 2021 -4.519M
June 30, 2021 -4.867M
March 31, 2021 -4.826M
December 31, 2020 -3.793M
Date Value
September 30, 2020 -2.701M
June 30, 2020 -1.605M
March 31, 2020 -0.677M
December 31, 2019 -0.48M
September 30, 2019 -0.492M
June 30, 2019 -0.53M
March 31, 2019 -0.476M
December 31, 2018 -0.396M
September 30, 2018 -0.273M
June 30, 2018 -0.112M
March 31, 2018 -0.043M

Gross Profit Definition

Annual, Interim and Preliminary Items - Commercial, Other Financial Companies

Read full definition.

Gross Profit (TTM) Range, Past 5 Years

View Gross Profit (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit (TTM) Benchmarks

View Gross Profit (TTM) Benchmarks
Start Trial
ANI Pharmaceuticals, Inc. 505.18M
Corcept Therapeutics, Inc. 816.73M
Veru, Inc. -0.113M
Johnson & Johnson 66.63B
Eli Lilly & Co. 66.44B